Gert De Hertogh
- Gastroenterology top 0.5%
- Genetics top 0.2%
- Inflammatory Bowel Disease 123
- Oncology top 1%
- Colorectal Cancer Treatments and Studies 18
- Epidemiology top 0.5%
- Microscopic Colitis 82
- Autoimmune and Inflammatory Disorders 28
- Immunology top 2%
-
- Helicobacter pylori-related gastroenterology studies 32
- Eosinophilic Esophagitis 21
-
- Retinal Diseases and Treatments 26
-
- Gastric Cancer Management and Outcomes 21
- Co-authors
- Séverine VermeireGert Van AsschePaul RutgeertsKarel GeboesMarc FerranteEric Van CutsemIngrid ArijsSabine Tejpar
- Cited by
- GastroenterologyGeneticsOncology
- Journals
- The Lancet (1 paper)Nature Communications (2 papers)Journal of Clinical Oncology (6 papers)
- Partner nations
- BelgiumUnited StatesSaudi Arabia
In The Last Decade
Gert De Hertogh
289 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Gastroenterology 862
- Genetics 3.6k
- Oncology 2.5k
- Epidemiology 2.8k
- Immunology 1.4k
Countries citing papers authored by Gert De Hertogh
This map shows the geographic impact of Gert De Hertogh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gert De Hertogh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gert De Hertogh more than expected).
Fields of papers citing papers by Gert De Hertogh
This network shows the impact of papers produced by Gert De Hertogh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gert De Hertogh. The network helps show where Gert De Hertogh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gert De Hertogh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2020 | 95 | |
| 9 | 2020 | 12 | |
| 10 | 2019 | 29 | |
| 11 | 2019 | 16 | |
| 12 | 2018 | 20 | |
| 13 | 2016 | 109 | |
| 14 | Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy. | 2016 | 14 |
| 15 | Prognostic Value of Serologic and Histologic Markers on Long-Term Outcomes in Ulcerative Colitis Patients With Mucosal Healing | 2012 | 5 |
| 16 | Inducible nitric oxide synthase inhibition improves nitrergic dysfunction in normoglycemic diabetes-prone biobreeding rats | 2009 | 2 |
| 17 | 2008 | 129 | |
| 18 | Effect of infliximab treatment on colonic mucosal gene expression profiles in patients with inflammatory bowel disease | 2008 | 1 |
| 19 | The EVEREST study: relationship between efficacy and K-RAS mutation status in patients with irinotecan-refactory MCRC treated with irinotecan and standard or escalating doses of cetuximab | 2008 | 4 |
| 20 | Intestinal immune activation in post-infectious functional dyspepsia | 2006 | 1 |
About Gert De Hertogh
Gert De Hertogh is a scholar working on Gastroenterology, Genetics and Epidemiology, having authored 309 papers that have together received 9.1k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (123 papers), Microscopic Colitis (82 papers), Helicobacter pylori-related gastroenterology studies (32 papers), Autoimmune and Inflammatory Disorders (28 papers), Retinal Diseases and Treatments (26 papers), Eosinophilic Esophagitis (21 papers), Gastric Cancer Management and Outcomes (21 papers) and Colorectal Cancer Treatments and Studies (18 papers). The work is most often cited by research in Gastroenterology (862 citations), Genetics (3.6k citations) and Oncology (2.5k citations). Gert De Hertogh has collaborated with scholars based in Belgium, United States and Saudi Arabia. Frequent co-authors include Séverine Vermeire, Gert Van Assche, Paul Rutgeerts, Karel Geboes, Marc Ferrante, Eric Van Cutsem, Ingrid Arijs, Sabine Tejpar, Ghislain Opdenakker and Freddy Penninckx. Their work appears in journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.